Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
16 mai 2024 16h02 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Palisade Bio to Present at Digestive Disease Week (DDW) 2024
15 févr. 2024 08h35 HE
|
Palisade Bio, Inc.
Carlsbad, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for serious...
Results of Pilot Study That Monitored Patients with Functional Dyspepsia, Gastroparesis and Vomiting Presented at Digestive Disease Week 2023
10 mai 2023 09h00 HE
|
G-Tech Medical
MOUNTAIN VIEW, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical today announced an oral presentation of an abstract entitled A Novel, Non-invasive, 6-day Wireless Motility Patch System...
Interim Results of Study That Used Non-invasive Wireless Patches to Monitor Myoelectric Activity of Crohn’s Disease Patients in Flare and Remission
09 mai 2023 09h00 HE
|
G-Tech Medical
MOUNTAIN VIEW, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced presentation of...
Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference
11 mai 2022 08h30 HE
|
Stella Diagnostics, Inc
SALT LAKE CITY, May 11, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient management strategies for precancerous and...
Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meeting
19 mai 2021 08h05 HE
|
Metacrine, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal...
Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update
13 août 2019 08h15 HE
|
Interpace Diagnostics Group, Inc.
Second Quarter Revenue Grew 14% Over the Prior Year and 19% Year to Date Over the Prior Year Acquired Growing BioPharma Services Business Net Revenue Guidance Increased Conference Call and...
Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week
09 mai 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
Company to Host Fellowship and Key Opinion Leader Programs PARSIPPANY, NJ, May 09, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that data from an...
Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
13 févr. 2019 07h00 HE
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI)...
PENTAX Medical Launches the SCOPEPILOT True 3D Endoscope Navigation System in Canada
03 mars 2017 07h30 HE
|
PENTAX Medical
MISSISSAUGA, Ontario, March 03, 2017 (GLOBE NEWSWIRE) -- PENTAX Medical, an industry leader in endoscopy imaging devices, has introduced SCOPEPILOT to the Canadian market and is showcasing this new...